000			04355cam a2200421Ii 4500
001			94707
003			ES-MaUEC
005			20230102112628.0
006			m o d
007			cr cnu---unuuu
008			161013t20162017sz of 001 0 eng d
020			_a3319414003 _q(electronic bk.)
020			_a9783319414003 _q(electronic bk.)
020			_z3319413988
020			_z9783319413983
035			_a(OCoLC)960643365 _z(OCoLC)960737969
040			_aN$T _cN$T _dYDX _dGW5XE _dEBLCP _dOCLCF _dIDEBK _dUAB _dIOG _dESU _dJBG _dIAD _dICW _dICN _dOTZ _dOCLCQ _dU3W _dES-MaUEC _bspa
050		4	_aRC548 _b2017 EB
245	0	0	_aClinical handbook of insomnia _cHrayr P. Attarian, editor.
250			_aThird edition.
264		1	_aSwitzerland _bSpringer International Publishing _c2016
264		4	_c2017
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aCurrent clinical neurology
505	0		_aPreface; Series Editor Introduction; Contents; List of Editor and Contributors; Part I: Chronic Insomnia Disorder; Chapter 1: Defining Insomnia; Introduction; Historical Perspectives; Definitions of Insomnia; Classifications; Classification Based on Duration and Severity; Duration of Illness; Severity of Illness; Commonalities and Problems with Current Definitions; Insomnia as a Subjective Complaint; Insomnia and Daytime Impairment; The Old Diagnostic Entity of Comorbid or Secondary Insomnia; Summary; References; Chapter 2: Epidemiology of Insomnia; Sociodemographic Determinants
505	8		_aGender Age; Ethnocultural Factors; Shift Work; Other Factors; Psychiatric Disorders; Morbidity and Mortality; Epidemiology of Hypnotic Use; Economic Impact of Insomnia; Conclusion; References; Chapter 3: Clinical Features, Diagnosis, and Differential Diagnosis; Introduction; Clinical Features; Clinical Subtype Features; Diagnostic Workup; Differential Diagnosis; Appendix 1; References; Chapter 4: Pathophysiology of Insomnia; Introduction; Historical Studies of Insomnia; Modeling Studies of Insomnia and Physiological Activation; The Effects of Poor Sleep
505	8		_aKey Pharmacologic Issues Prescription and Non-prescription Agents Approved by FDA for Treatment of Insomnia; Benzodiazepine Receptor Agonists; Mechanism of Action; Pharmacokinetics; Efficacy; Safety; Residual Effects; Sedation; Driving Performance; Fall Risk; Amnesia; Complex Behaviors During Sleep; Mortality Risk; Tolerance, Dependence, Abuse Potential; Discontinuation Effects; Melatonin Receptor Agonists; Ramelteon; Melatonin; Orexin Antagonists; Histamine (H1) Antagonists; Selective H1 Antagonist: Doxepin 3-6 mg; Nonselective H1 Antagonists: Diphenhydramine, Doxylamine
505	8		_aNeurocognitive Perspective Assessment and Measurement; Self-Report Assessment; Objective Assessment; Cognitive-Behavioral Treatment; Therapeutic Regimen; First-Line Interventions; Stimulus Control Therapy; Sleep Restriction; Sleep Hygiene Education; Cognitive Therapy; Relaxation Training; Phototherapy; Complicating Factors; Treatment Compliance; Comorbidity of Mental and Medical Disorders; CBT and Sedative Hypnotics; The Efficacy of CBT; Abbreviated Versions of CBT-I; Technology and CBT; Summary; References; Chapter 7: Pharmacological Treatment of Insomnia; Introduction
505	8		_aPoor Sleep in Insomnia Patients The Development of Insomnia; Medical Implications of These Physiological Arousal Data; Elevated Blood Pressure/Hypertension; Glycemic Control/Diabetes; Depression; Immune Function; Mortality; Discussion; References; Chapter 5: Prognosis and Complications; Prognosis and Complications; Psychiatric Disorders; Neurocognitive Function; Metabolic Disorders; Cardiovascular Disease; Burden of Illness; References; Chapter 6: Cognitive Behavioral Therapy for Insomnia; Theoretical Perspectives on Insomnia; Behavioral Perspective; Cognitive Perspective
650		7	_aInsomnio _2embne _0(OCoLC)fst00974221 _0 _9140237
700	1		_aAttarian, Hrayr P., _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-41400-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988			_aSpringer_Medicine_2017
998			_b02/2018 _dz _e- _zSI
999			_c94707 _d94707 _x1